Both in Pharmaceuticals
Geron vs ArriVent BioPharma
Over the past year GERN returned −27.9% and AVBP returned −19.5%; their daily moves had a correlation of 0.09.
GERN −27.9% AVBP −19.5%Growth of $1, one year, split-adjusted
| Metric | GERN | AVBP |
|---|---|---|
| Price | $0.8944 | $14.87 |
| Market cap | $574.6M | $733.2M |
| Today | −5.47% | −6.77% |
| 1 month | −26.1% | −48.6% |
| 6 months | −43.4% | −50.4% |
| Year to date | −32.2% | −26.1% |
| 1 year | −27.3% | −20.4% |
| Revenue growth (YoY) | +17.2% | — |
| Gross margin | 83.9% | — |
| Net margin | −29.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.8× | — |
| Net cash | $51.1M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 60.1% | 153.2% |
| Short % of float | 11.9% | 20.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).